SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Biogen Idec, Inc. (North Carolina) and Swedish Orphan Biovitrum AB Announce Decision to Advance Long- Lasting Hemophilia A Therapy into a Registrational Trial